ENFINIA IVT Ready DNA delivers high-fidelity, long linear DNA with encoded poly(A) tails up to 3X faster & ready for direct input into mRNA workflows.

Thierry Van Nieuwenhove, CEO at Quotient Sciences, said: “This is a pivotal moment for RNA drug development. The combined ...

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions New all-in-one IVT kit can deliver up ...

The integrated service aims to streamline the journey of mRNA drug products from conception to clinical trials.

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for pancreas-related diseases, including cancer and diabetes. A new UNLV study by a team ...

Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved ...

Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation centre, CPI, have signed a memorandum of understanding (MoU) to form a Joint Venture ...